Stockscreener 앱 받기
12.40
3.13%
-0.40
시간 외 거래:
12.48
0.08
+0.65%
전일 마감가:
$12.80
열려 있는:
$12.76
하루 거래량:
4.66M
Relative Volume:
1.55
시가총액:
$925.65M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-13.48
EPS:
-0.92
순현금흐름:
$-38.74M
1주 성능:
-16.39%
1개월 성능:
+2.86%
6개월 성능:
+22.65%
1년 성능:
+117.54%
1일 변동 폭
$12.35
$12.91
1주일 범위
$12.35
$14.86
52주 변동 폭
$5.31
$17.43
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
12.40 | 955.51M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Leerink Partners | Outperform |
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2024-08-26 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
Is CorMedix Inc. backed by strong institutional buyingProduct Launch & Entry Point Confirmation Signals - خودرو بانک
When is the best time to exit CorMedix Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
CorMedix at Cantor Global Healthcare Conference: Strategic Growth and Diversification - Investing.com Australia
Will CorMedix Inc. benefit from current market trendsWeekly Stock Report & AI Optimized Trading Strategy Guides - خودرو بانک
Using RSI to spot recovery in CorMedix Inc.July 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
Is CorMedix Inc. stock a smart retirement pickMarket Rally & Accurate Entry/Exit Alerts - خودرو بانک
Real time pattern detection on CorMedix Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - Newser
Can trapped investors hope for a rebound in CorMedix Inc.July 2025 WrapUp & Verified Chart Pattern Signals - Newser
Comparing CorMedix Inc. in custom built stock radars2025 Bull vs Bear & Short-Term Trading Alerts - Newser
Deerfield Management Sells Melinta Therapeutics To CorMedix - citybiz
Is CorMedix Inc. showing signs of accumulationJuly 2025 Outlook & Stock Portfolio Risk Management - Newser
Cormedix Inc. shares fall 1.05% premarket after presenting at Cantor and Morgan Stanley conferences. - AInvest
How high can CorMedix Inc. stock goJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What the charts say about CorMedix Inc. todayWeekly Trend Recap & Daily Profit Maximizing Trade Tips - Newser
CorMedix to Participate in Upcoming Investor Conferences - 富途牛牛
Sentiment analysis tools applied to CorMedix Inc.2025 Dividend Review & Free Community Consensus Stock Picks - Newser
Statistical indicators supporting CorMedix Inc.’s strengthProduct Launch & Comprehensive Market Scan Reports - Newser
Institutional Confidence Rises as CorMedix Inc. (CRMD) Hits Profitability - MSN
Analyzing CorMedix Inc. with multi timeframe charts2025 Key Highlights & Entry Point Confirmation Alerts - Newser
CorMedix Inc.’s volatility index tracking explainedBull Run & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-09-04 02:05:07 - Newser
Will CorMedix Inc. benefit from seasonality2025 Earnings Impact & Free High Return Stock Watch Alerts - خودرو بانک
Will CorMedix Inc. benefit from AI trends2025 Sector Review & Momentum Based Trading Signals - خودرو بانک
CorMedix completes $300M acquisition of Melinta Therapeutics - NJBIZ
Wall Street Analysts Think CorMedix (CRMD) Could Surge 32.04%: Read This Before Placing a Bet - sharewise.com
Using portfolio simulators with CorMedix Inc. included2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Signal strength of CorMedix Inc. stock in tech scannersJuly 2025 Volume & Daily Stock Trend Watchlist - Newser
CorMedix Inc. stock chart pattern explainedMarket Growth Review & Verified Technical Trade Signals - Newser
Using Bollinger Bands to evaluate CorMedix Inc.Day Trade & Community Consensus Stock Picks - Newser
CorMedix Inc. stock momentum explainedJuly 2025 Spike Watch & Low Volatility Stock Recommendations - Newser
CorMedix Inc. stock volume spike explainedShare Buyback & Capital Protection Trading Alerts - Newser
What makes CorMedix Inc. stock price move sharplyWeekly Trend Summary & Smart Money Movement Alerts - Newser
What is the long term forecast for CorMedix Inc. stockJuly 2025 Catalysts & Accurate Entry/Exit Alerts - خودرو بانک
Heatmap analysis for CorMedix Inc. and competitorsPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
CorMedix Shares Drop 1.28% as $380M Volume Ranks 291st in Market Activity, $300M Melinta Acquisition Fuels Growth - AInvest
Cormedix Inc. shares fall 1.85% after-hours following the completion of Melinta Therapeutics acquisition. - AInvest
CorMedix Completes Acquisition of Melinta Therapeutics - citybiz
How CorMedix Inc. stock performs during market volatility2025 Price Action Summary & Low Drawdown Trading Strategies - Newser
Support Test: Should you buy the dip on CorMedix Inc.2025 Big Picture & Weekly High Return Stock Opportunities - خودرو بانک
Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path? - sharewise.com
What’s the recovery path for long term holders of CorMedix Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):